Clinical Trials on Oxaliplatin

Total 26 results

Sun Yat-sen University
Second Affiliated Hospital of Guangzhou Medical University

Not yet recruiting

HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama

Liver Neoplasms | Hepatocellular Carcinoma | Bevacizumab | Toripalimab | Oxaliplatin
UNICANCER

Active, not recruiting

Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. (RILUZOX-01)

Oxaliplatin-induced Peripheral Neuropathy

France
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients

Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients

Bangladesh
Abramson Cancer Center of the University of Pennsylvania

Terminated

A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

GI Patients on Oxaliplatin Containing Regimen

United States
Soonchunhyang University Hospital

Completed

A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Efficacy | Gemcitabine | Advanced Biliary Tract Adenocarcinoma | Oxaliplatin | Combination Chemotherapy

Korea, Republic of
Chang Gung Memorial Hospital

Unknown

Auricular Acupressure : Improves Oxaliplatin-induced Peripheral Neuropathy

Chemotherapy | Oxaliplatin-induced Peripheral Neuropathy

Taiwan
AIPING ZHOU

Not yet recruiting

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Immunotherapy | Sintilimab | Locally Advanced Solid Tumor | Oxaliplatin | HER2-positive | Gastric or Gastroesophageal Junction Adenocarcinoma | S-1

China
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

Docetaxel, Oxaliplatin and Fluorouracil

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

Capecitabine | MSI-H Colorectal Cancer | Oxaliplatin | Tislelizumab
Soonchunhyang University Hospital

Unknown

Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

Gastric Cancer | Elderly | Oxaliplatin | S-1 | First-Line
Blokhin's Russian Cancer Research Center

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (RusGCG-01)

Stomach Neoplasms | Gastrointestinal Neoplasms | Docetaxel | Oxaliplatin | Fluoruracil | Irinotecan Hydrochloride

Russian Federation
AIPING ZHOU

Recruiting

Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer

S-1 Plus Oxaliplatin

China
Hangzhou Cancer Hospital

Completed

CCRT for Esophageal Cancer.

Esophageal Cancer | Paclitaxel | Concurrent Chemoradiotherapy | Oxaliplatin
Shanghai Zhongshan Hospital

Unknown

Early Diagnosis of Oxaliplatin-induced Portal Hypertension

Colorectal Cancer | Gastroesophageal Varices | Received Oxaliplatin-based Chemotherapy

China
Shanghai Zhongshan Hospital
First Affiliated Hospital of Wenzhou Medical University; Anhui Provincial Hospital and other collaborators

Recruiting

Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding

Gastrointestinal Cancer | Gastroesophageal Varices Hemorrhage | Received Oxaliplatin-based Chemotherapy

China
University Hospital, Clermont-Ferrand

Completed

Long Term Effect of Oxaliplatin Treatment in Cancer Survivors (PREVOX)

Adult | Colorectal Cancer Survivors | Oxaliplatin Regimen

France
Seoul National University Bundang Hospital
Seoul National University Hospital; SMG-SNU Boramae Medical Center; Yuhan Pharmaceutical... and other collaborators

Completed

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Metastatic or Recurrent Colorectal Cancer | Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan | Salvage Chemotherapy

Korea, Republic of
Shanghai Zhongshan Hospital

Unknown

Oxaliplatin-induced Portal Hypertension

Colorectal Cancer | Gastroesophageal Varices Hemorrhage | Received Oxaliplatin-based Chemotherapy

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Huashan Hospital; The Second Affiliated Hospital of Harbin Medical University; Meng Chao Hepatobiliary Hospital of Fujian Medical University

Not yet recruiting

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Carcinoma | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Antineoplastic Agents | Oxaliplatin | Donafenib | Fluorouracil | Antimetabolites

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Bevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutated

China
Ciusss de L'Est de l'Île de Montréal

Terminated

Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC (CHIPNOL)

Colorectal Neoplasms | Hyperthermia | Oxaliplatin

Canada
Zhejiang Cancer Hospital

Recruiting

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors

Hepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | Pharmorubicin

China
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer

Gastrointestinal Neoplasms | Intestinal Neoplasms | Rectal Diseases | Rectal Neoplasms | Lymph Node Metastasis | Oxaliplatin | Cancer of Rectum and Anus

China
Astellas Pharma Global Development, Inc.

Recruiting

A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma (ILUSTRO)

Gastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)

United States, Italy, Japan, Korea, Republic of, Taiwan, France
Hong Kong Baptist University
Queen Mary Hospital, Hong Kong; Princess Margaret Hospital, Hong Kong

Not yet recruiting

Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-induced Neurotoxicity in Colorectal Cancer Patients

Colorectal Cancer | Neurotoxicity | Oxaliplatin | Electro-acupuncture

Hong Kong
Samsung Medical Center

Terminated

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

Phase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin

Korea, Republic of

Clinical Trials on Oxaliplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations